Pulmonary hypertension: an emerging risk in hemoglobin disorders
<p>Pulmonary hypertension (PH) is one of the main cardiovascular complications in haemoglobinopathies and is considerably implicated in patients’ morbidity and mortality. In thalassemia intermedia, PH is found in about 60% of traditionally managed patients and represents the main cau...
Main Authors: | D. Farmakis, A. Aessopos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-12-01
|
Series: | Thalassemia Reports |
Subjects: | |
Online Access: | http://www.pagepressjournals.org/index.php/thal/article/view/308 |
Similar Items
-
RASA3 is a candidate gene in sickle cell disease‐associated pulmonary hypertension and pulmonary arterial hypertension
by: Clare C. Prohaska, et al.
Published: (2023-04-01) -
Pulmonary function abnormalities in non-splenectomized and splenectomized adult hemoglobin E/β-thalassemia patients and their correlation with pulmonary hypertension
by: Prapaporn Pornsuriyasak, et al.
Published: (2013-11-01) -
First and Second Level Haemoglobinopathies Diagnosis: Best Practices of the Italian Society of Thalassemia and Haemoglobinopathies (SITE)
by: Giorgia Mandrile, et al.
Published: (2022-09-01) -
Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives
by: Coons JC, et al.
Published: (2023-07-01) -
Prevalence of Pulmonary Hypertension in Patients with Thalassemia Intermedia in 2009: a single center’s experience
by: Hassan Mottaghi Moghaddam, et al.
Published: (2015-07-01)